Abstract

Aim: This work aims to contribute toward development of preventive measures for the control of monkeypox (mpox) virus disease through computational design of a multiepitope vaccine. Methods: To accomplish this, we employed a robust immunoinformatics approach to design a putative chimeric vaccine candidate from 18 viral transmembrane proteins. Results: The resulting chimeric vaccine candidate is a 76.4 kDa protein containing 687 amino acids with an estimated isoelectric point of 9.39. In addition, it was predicted to adopt a stable 3D conformation that harbors discontinuous B-cell epitopes and strongly interacts with key immune receptors. Conclusion: The designed hypothetical antigen is a valuable addition to the collection of prospective vaccine candidates for future development and trials against the re-emerging mpox disease.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call